ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs

May 30, 1980

Watson To Head Genome Research

September 30, 1988

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008